Use of DNA Testing and Gene Expression Profiling to Help Transition Kidney Transplant Recipients to Belatacept-only Immunosuppression

NAEnrolling by invitationINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 14, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

December 31, 2026

Conditions

Kidney Transplant Immunosuppression

Interventions

DIAGNOSTIC_TEST

Allosure and TruGraf

Precision medicine will be employed to withdraw immunosuppression in kidney transplant recipients.

OTHER

Immunosuppression Taper

An immunosuppression taper will be employed over a 12-month period for those that are deemed immune quiescent.

Trial Locations (1)

University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors

lead

University of Texas Southwestern Medical Center

OTHER